The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.

A bacteria-only sugar has become the Achilles’ heel that could help defeat deadly superbugs.

Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have ...

Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-based therapeutics, today announced that the first patient has been dosed in a Phase 1a/1b ...

Decisions may depend on thymoma and what type of auto-antibodies are present ...

The link between nutrition and the immune system does exist, and the state of the intestinal microbiota plays a key role in ...

How does origami-like DNA affect brain development? How do cancer-immune cell interactions prevent immune cell activity in tumors?Two breakthrough ...

Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed ...

CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...

Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work for many ...

Cardiologists have spent decades trying to stabilize the fatty plaques that clog arteries, but a new wave of immunotherapy is ...

Objectives Female sex and anticitrullinated protein antibodies (ACPA) are associated with higher disease activity in ...